Order intake at C-RAD totaled 88 MSEK in 2015

Report this content

C-RAD AB, with its four fully owned subsidiaries and three international sales companies, is active in the field of radiation therapy. Just prior to its Extra General Meeting C-RAD is presenting order intake and revenue figures for fiscal year 2015.

The order intake for C-RAD totaled 88 MSEK during fiscal year 2015. Orders for Positioning Products (which includes Sentinel™ and Catalyst™) increased by 39 % to 63,4 MSEK. The Service segment generated orders of 10 MSEK, which is an increase of 113 %.

Revenues for the entire group amounted to 62,3 MSEK in the same period. This is an improvement of 16 % compared to fiscal year 2014.

Please note: The stated revenue shall be considered preliminary and is based on unaudited results. The results are therewith subject to changes.

C-RAD management decided to disclose order intake and revenue information prior to the Extra General Meeting. The comprehensive full year report for fiscal year 2015 will be published on February 8, 2016.

 

About C-RAD

C-RAD develops innovative solutions for use in advanced radiation therapy. The C-RAD group offers products and solutions for patient positioning, tumor localization and radiation treatment systems. End users are radiation therapy clinics worldwide. All product development is conducted in three fully owned subsidiaries: C-RAD Positioning AB, C-RAD Imaging AB and C-RAD Innovation AB, all of which are located in Uppsala, Sweden. Employees currently number 40. C-RADs business originates from research and development at Karolinska Institutet in Solna, Sweden. Sales of the companys first product, the C-RAD SentinelTM, started in 2007. Cooperation agreements have been signed with Elekta (Sweden), Varian (USA) and IBA (Belgium). C-RAD is represented by distributors specialized in radiation therapy on major markets. C-RAD has established three companies for direct sales: C-RAD Inc. in the US, C-RAD GmbH in Germany and C-RAD WOFE in China. Cyrpa International SPRL, a Franco-Belgian laser company, is a wholly owned subsidiary whose operations are being integrated. C-RAD AB is listed on NASDAQ Stockholm.

For more information on C-RAD, please visit www.c-rad.com.

 

For further information:

Tim Thurn, CEO C-RAD AB, Phone +46-18-666930, Email investors@c-rad.com

The above information is price-sensitive and must therefore be disclosed under the Securities Market Act (2007:528).